Excess Body Fatness during Early to Mid-Adulthood and Survival from Colorectal and Breast Cancer: A Pooled Analysis of Five International Cohort Studies

Hadrien Charvat, Heinz Freisling, Hwayoung Noh, Mia M. Gaudet, Marc J. Gunter, Amanda J. Cross, Konstantinos K. Tsilidis, Anne Tjønneland, Verena Katzke, Manuela Bergmann, Claudia Agnoli, Charlotta Rylander, Guri Skeie, Paula Jakszyn, Ann H. Rosendahl, Malin Sund, Gianluca Severi, Shoichiro Tsugane, Norie Sawada, Hermann BrennerHans Olov Adami, Elisabete Weiderpass, Isabelle Soerjomataram, Melina Arnold

    Research output: Contribution to journalArticlepeer-review

    6 Citations (Scopus)

    Abstract

    Background: Here, we explore the association between excess weight during early to mid-adulthood and survival in patients diagnosed with breast and colorectal cancer, using a pooled analysis of five cohort studies and study participants from 11 countries. Methods: Participant-level body mass index (BMI) trajectories were estimated by fitting a growth curve model using over 2 million repeated BMI measurements from close to 600,000 cohort participants. Cumulative measures of excess weight were derived. Data from over 23,000 patients with breast and colorectal cancer were subsequently analyzed using time-to-event models for death with the date of diagnosis as start of follow-up. Study-specific results were combined through a random effect meta-analysis. Results: We found a significant dose–response relationship (P trend ¼ 0.013) between the average BMI during early and mid-adulthood and death from breast cancer, with a pooled HR of 1.31 (1.07–1.60) and the time to death shortened by 16% for average BMI above 25 kg/m2 compared with average BMI less than or equal to 22.5 kg/m2, respectively. Similar results were found for categories of cumulative time spent with excess weight. There was no association between excess body fatness during early to mid-adulthood and death in patients with colorectal cancer. Conclusions: Excess body fatness during early to mid-adulthood is associated not only with an increased risk of developing cancer, but also with a lower survival in patients with breast cancer.

    Original languageEnglish
    Pages (from-to)325-333
    Number of pages9
    JournalCancer Epidemiology Biomarkers and Prevention
    Volume31
    Issue number2
    DOIs
    Publication statusPublished - 1 Feb 2022

    Cite this